Chancery OKs $12.5M Settlement In Ionis-Akcea Merger Suit
A Delaware vice chancellor has approved a $12.5 million settlement to end an Akcea Therapeutics Inc. investor class suit alleging controlling stockholder Ionis Pharmaceuticals Inc. acquired the balance of Akcea's stock...To view the full article, register now.
Already a subscriber? Click here to view full article